The Suppression of Medulloblastoma Cell Migration Using Clinically Significant Doses of Simvastatin through Mevalonate Pathway Targeting

<b>Aims:</b> Medulloblastoma (MBs), the most prevalent malignant paediatric brain tumour, exhibits distinct subgroups—Wingless (WNT), Sonic Hedgehog (SHH), Group 3 (G3), and Group 4 (G4)—and each is characterized by unique molecular signatures and clinical outcomes [...]

Bibliographic Details

Published in:	Proceedings
Main Authors:	Charley Comer, Maria Victoria Niklison-Chirou
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	Medulloblastoma simvastatin
Online Access:	https://www.mdpi.com/2504-3900/100/1/6